Clinical Trial Update: To Identify HLA-A1101-restricted Peptide Epitopes Derived From Novel Oncoantigens (URLC10, KIF20A, and CDCA1) Applicable for Cancer Vaccine in Singapore

View source ↗

Summary

This clinical trial update describes research to identify HLA-A1101-restricted peptide epitopes from URLC10, KIF20A, and CDCA1 for a cancer vaccine in Singapore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Anonymous Donors at Blood Donation Center (NUH) | Status: UNKNOWN